From China With IO: Lilly Bets $1bn+ To Take Innovent Drug Global

Chinese Firm To Internationalize Via Wider Partnership

 
• By Brian Yang
  
China - Suzhou City
LILLY OBTAINS GLOBAL RIGHTS TO IO DRUG FROM SUZHOU-BASED INNOVENT BIO • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer